Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk. Smarter screening strategies that can improve the accuracy of diagnosing lethal prostate cancer are urgently needed. Through a prospective… Read More »
Despite its common use, the PSA blood test cannot distinguish between low-grade cancer and high-grade cancer. Low-grade cancer can be monitored and does not need active treatment whereas high-grade cancer requires surgery and radiation therapy.
A new urine test that can detect genetic changes correlated with prostate cancer correctly identified cancer grade in 92% of men with elevated prostate-specific antigen (PSA) levels had high-grade cancers.
A new study, published in… Read More »
Tagged with: African American Men, annual physical, Columbia University Medical Center, JAMA Oncology, James McKiernan, John K. Lattimer, MD, New York-Presbyterian/Columbia, prostate cancer, prostate cancer diagnosis, real men get tested, real men speak up, regular check ups, silence is not a cure, urine test for postate cancer
